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Editorial
The compelling rationale for less preoperative testing
The study by Charpak et aL ~ in this issue is one of more than twenty studies (summarized in reference 2) demonstrating that the number of preoperative tests can be reduced, without adversely affecting patient care. While Charpak et al. focused on one specific test, the chest x-ray, the overall conclusion of studies either limited to one test, or including a battery of tests is the sameapproximately 60 per cent of preoperative testing could be eliminated without adversely affecting patient care. One therefore has to ask two questions: Why isn't this being done? Why are we still seeing studies like that of Charpak et al. which appear to reconfirm what is already known?
Because of familiarity, I will address this topic in terms of health care and medical practice patterns in the United States which, although on a different financial basis than in Canada, nevertheless illustrate the general problems of implementing a strategy of lesser preoperative testing.
Let us first examine the subject in two ways.
(1) Are there advantages to ordering fewer tests -advantages to society, to patients, aud/~r to providers? (2) If tbere are advantages, why is it taking us so long to implement these strategies? Is it the millieu in which testing is ordered or is it because the advantages to providers aren't as great as the advantages to society?
First, are there advantages to ordering fewer tests? The data from many published studies are fairly consistent and show that there are advantages to society in providing less testing; that is, cost savings and perhaps imprOvement of patient care by reducing risk to patients. This latter statement may seem surprising. In medicine, one almost always assumes a priori that doing more testing would be better, and produce more of a benefit. But this is not necessarily true, especially if the extra testing yields false-positive results or clinically unimportant borderline positive results which lead to both delays in the surgical Professor and Chairperson, Department of Anesthesia and Ua"iti:al Care, The University of Chicago, 58~.1 South Maryland Avenue, Chicago, Illinois, 60637. schedule and, more importantly, increased risk to the patient as more testing is done and more judgements are based on the raise-positive or borderline tests. Increased risk created by extra testing is actually one of the new risks which have emerged during the last two decades.
The Kaiser organization, for example, instituted multiphasic screening with 16 tests in the mid 1960's. While previous to that tests were ordered singly or in small groups to confirm clinical impressions, the advent of automated screening batteries and of the "executive physical" led to increased numbers of tests. The health maintenance organizations in the United States were one of the main proponents of screening tests. The rationale appeared good and very logical. You could screen cheaply and spot abnormalities before they led to symptoms and thus prevent illness from occurring. It has not worked out this way and, in fact, extra tests have simply posed extra risk to the patient, because of the iatrogenic disease caused by the pursuit of and treatment of borderline abnormal and false-positive results. In fact, the Kaiser organization has dropped the majority of the batteries of screening tests, and certainly for preoperative care. This is not to say that some screening is not indicated -some obviously is, such as the mammogram for females over the age of 50, the stool for occult blood test for patients over the age of 40, the "pap smear,", etc. But random screening, without being selective, may not be more of a benefit.
Few studies have examined the adverse results to patients of increased tests and the follow-up of falsepositive tests. We examined this question retrospectively for chest x-rays. 3 In this study, 386 extra chest x-rays were done that were not indicated, in a population of 606 patients. One problem, an elevated hemi-diaphragm and probable phrenic nerve palsy was found that may have improved care for that pattern (1/396). In addition, three lung shadows were found, which resulted in three sets of invasive tests and one thoraeotomy, without any disease being discovered and with considerable morbidity for the three patients, including one pneumothorax and four months of disability.
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In another study, 4 a series of eight years of routine testing of 121 nursing home patients, who were on the average 89 years of age, resulted in no benefit being derived from 74 per cent of the tests. This result could have been predicted before the testing began, in fact, one patient was seriously and adversely hurt by the extra testing and treatments it engendered. Thus, I perceive that selective testing of the type done before automated screening batteries is better tier patient care, as well as saving society approximately 50 to 60 per cent of the expense of this testing.
Blue Cross/Blue Shield has estimated that more than 30 billion dollars is spent in Noah America on preoperative testing and the subsequent follow-up evaluations, because of those tests. They have further estimated that 18 billion dollars, or 60 per cent of this, could be saved by appropriate ordering of tests, based on the history or on findings of the physical examination. Since selectively ordering tests is better for patients and saves money, we conclude that providers must perceive a benefit from the current extra testing for them to continue this adverse and more costly pattern of care. Perhaps these perceived benefits are the medico/legal protection or an efficiency of scheduling of their lives. I believe both are perceived, but neither are true. Let me explain the basis for this belief.
Are extra tests medico/legal protection? The answer is a resounding "no." There are now a series of reports (reviewed in references 2 and 3) that show that between 30 and 60 per cent of all unexpected abnormalities found on preoperative laboratory tests are not noted preoperatively. Clearly this is the case with many preoperative x-rays, where the report is not on the chart before the start of the anaesthetic. An abnormality not appropriately pursued is a greater liability risk than is an abnormality that is not detected preoperatively. 5 It appears that extra testing, testing that is not indicated by history, is an extra risk to patients and is an extra medico/legal risk to physicians.
Thus it seems that the only advert 'tage to continuing the present system of the routine ordering of batteries of screening tests is the perceived efficiency for operating room schedules by surgeons attempting to appease anaesthesiologists. What could solve the problem is a system (but still with surgeon and anaesthesiologist intervention based on clinical judgement) where the anaesthesiologist agrees that certain eondifions indicate specific tests and certain other conditions do not require tests. If one could automate the system the surgeons could institute it in the same time that they would normally take to order the current battery of tests.
The study by Charpak et al. ,i where the surgeons and anaesthesiologists agreed for research purposes on set conditions for ordering chest x-rays is an example of such a system. The set conditions were: any lung disease, any 215 cardiovascular disease, actual malignant disease, major surgical emergencies, current smoking history in patients ->50 years old, immuuodepression, and lack of a prior health examination in immigrants. Even so, in the study by Charpak et al., 271 chest x-rays were ordered which were not recommended and 596 were not ordered although they were recommended, out of a total of 1426 chest x-rays that should have been ordered in this group of 3,849 patients. If there were this many errors in the ordering of one laboratory test, inclusion of more tests would certainly generate more errors.
What appears needed to reduce the error rate for ordenng is a system which generates the medical history and from the history suggests tests for the physician to order. We tested a protocol in which the results of a history filled out by the patient on six pages of questions suggested which laboratory tests should be ordered. 3 '6 This system only worked when a health research nurse was present to integrate the results of the history into agreed-upon indications for each test. It appears, then, that an automated system is necessary, since hiring a health nurse in every location where physicians order preoperative tests is likely to be more expensive than the testing itself. We tried a computer-based system based on a Macintosh computer, hut this did not work, because many patients are not "computer literate." We are now trying another system which will give a "health quiz" to patients on a simple four-button computer machine like the child's game "Donkey Kong, Jr." The surgeon or anaesthesiologist will have this device in his/her office, where it can be used by the patient. The device asks patients yes/no questions and then prints their answers, as well as the suggested laboratory tests, based on the agreed upon indications and the patients" answers. The physician, surgeon, or anaesthesiologist can over-ride or add to the suggested tests, before the preoperative testing is actually ordered.
Thus, whether or not an easy implementation mechanism is available, it appears that less testing is in order. Less testing will reduce the risk to the patient, reduce medico/legal risks for the physician, lessen costs to society, and probably make operating room schedules more efficient, by not creating the need to pursue falsely positive or slightly abnormal results with which the patient normally lives. I believe that the time has come when the studies of Charpak et al., and others, will beget benefit to society and that less but more appropriate testing wilt be a reality for the future. Parce qu'il m'est plus familier, je vais adresser ee sujet selon les normes de soin de sant6 et le profil de pratique m~dic',de connus aux Etats-Unis. MalgrE qu'ils soient diffErents financi~rement du syst~me Canadien ces normes de pratique illustrent n~anmoins les probl~mes g~n~raux qui emp~.chent l'implantation d'une strategic pour diminuer les tests prroprratoires.
La rationnelle pour la
Examinons d'abord le sujet de deux fa~ons. 1) Y-a-t-Jl des avantages ~ la soeiEtE, aux patients, et~ou b. aux pourvoyeurs ~ diminuer le nombre de ees tests? 2) En l'absence d'avantages, pouquoi l'applieation d'une tulle strat~gie prend-t-elle du temps? Cela dEpendrait-il du milieu ou serait-ce puree que les avantages que cette strat~gie amine anx pourvoyeurs ne seraient pus aussi grands que les avantages/~ la socirtr?
Premi~rement y-a-t-il des avantages ~t diminuer te hombre de tests? Les donnres publi~es dam plusieurs 6indus sont raisonnablement consistantes et drmontrent des avantages ~, la soci~tE quand on adopte une pa.reille strat6gie que ce soit pax la diminution des cofits ou peut ~tre par la diminution des risques que peuvent amener ces tests. C.e dernier point peut sembler surprenant. En mrdecine on peut toujours assumer h priori qu'en faisant plus de tests on aboutira ~ un plus grand b~nrfiee au patient_ Ceci n'est cependant pas toujours vrai. Spreialement si le surplus de tests aboutit ~. des r~uttats faussement positifs ou des rrsultats positifs mais sans importance elinique. Le retard duns la cEdule chirurgicale et le risque accru que cela amrne sera bast sur des tests faussement positifs. Un risque augmentE erie par des tests CANADIAN JOURNAL OF ANAESTHESIA supplrmentaires est en fait un des not~veaux risques qui a vu le jour dans les deux demi~res drcennies.
L'organisation Kaiser, par exemple, a institu6 un syst~me de d~pistage multiphasique comprenant 16 tests vers le milieu des annres 1960. Alors qu'aupamvant les tests 6talent demandrs ~t l'unit6 ou par petits groupes afin de confirmer les impressions cliniques, l'&ablissement de ce syst~me de drpistage automatisE a amen6 une surmultiplication des tests accomplis. Les organisations de sant6 des Etats-Unis ont favoris~, ces tests de dEpistage. La rationnelle apparaissait bonne et logique. On pouvait drpister h bas prix, d~tecter des anomalies avant le d&lenchement des syrnpt6mes et prrvenir aJnsi des maladies. Cependant le rEsultat trait diffrrent car en fait les tests suppl~mentaires ont cr~ un risque supplEmentake [atrog~ne au patient par le traitement des patients qui pr~sentaient des tests h la limtte de la normale ou des rrsultats faussement positifs. En fait l'organisation Kaiser a abandonnE la majorit6 des batteries de tests de drpistage et plusieurs des tests pr~ol~ratoires. Ceci ne veut pas dire que les tests de d~pistage ne sont pus indiqu~s: quelques-uns de toute 6vidence le sont comme c'est le cas de la mammographie chez les femmes dont l'~ge est suprrieur a 50 ans, le test de dEpistage du sang duns les selles chez les patients figEs de plus de 40 ans, le "pap smear", etc. Un drpistage randomis~ sans ~Ixe srlectif pent ne pas ~tre brnrfique.
Peu d'Etudes se sont attard~es sur I'effet nrfaste d'une augmentation des tests et la poursuite des tests fauxpositifs. On a examin6 cette question r~trospeetivement pour les rayons-x poulmonaires. 3 Dans cette 6tude, 386 ravons-x pulmonaires additionnels ont 6t6 demandrs sans indication sp~cifique pour une population de 606 patients. Un seul probl~me pouvant amEliorer les scfins du patient fut detect6 soit une sur~l~vation de diaphragme suggrrant la possibilit~ d'une paralysie du neff phrrnique (1/386). En plus, trois opacitrs pulmonaires fttrent drtectres provoquant ainsi d'autres tests invasifs et crEant une morbiditY, accrue dont une thoracotomie qui fur t~rgative, un pneumothorax et une incapacitY, de quatre mois.
Duns une autre 6rude, 4 ob des tests de routine 6talent faits durant huit ans duns 121 centres de soins de patients ~-g~s en moyenne de 89 arts, on a dEmontr6 qu'aucun brn~fiee n'a 6t6 tire ~ partir de 74 pour cent des tests. Ce r~sultat pouvait ~tre pr~dit avant le d~but de I'Etude. En fait, les tests sapplEmentaires et les traitements qu'ils ont engeudr~s ont nui srrieusement ~ un patient du groupe. Ainsi, je crois que demander des tests s~lectifs du type qu'on faisant avant l'instauration des batteries de drpistage automatisE serait meilteur pour les soins des patients et ~eonomiserait/~ la sociEt~ approximat~vement 50 h 60 pour cent des dEpenses.
Les compagnies d'assurance Blue Cross/Blue Shield ont estim6 que plus de 30 billions de dollars sont dCpens~s dans le continent Nord Am6ricain sur des tests pr~op6ra-toires et la poursuite des r6sultats de ces tests, lls ont de plus estim6 que 18 billions de dollars, ou 60 ponr cent de ceci pourraient 6tre sauv6s par une demande appropri6e des tests bas6s sat l'histoire ou sur les r6sultats de l'examen physique. Etant donn6 qu'une demande s41ec-tire des tests est meilleure pour les patients et pent sauver de I'argent on conelut que les pourvoyeurs dc ces tests doivent y percevoir des b6n6fices personnels afin de continuer ee programme dispendieux. I1 est possible que les b~n~fices per~us soient la protection m6dico-14gale ou une meilleure efficacit6 dans la c4dule de leur vie. Je erois que ces deux points sont per~us mais qu'aucun d'eux n'est vrai, Laissez-moi expliquer mon point de vue. Est-ce que des tests suppl6mentaires am~nent une plus grande protection m6dieo-l~gale? La r6ponse est un "non" ~clatant. Ii y a actuellement une s6rie d'6tudes (revis6es duns les r~f~rences 2 et 3) qui d6montmnt qu'entre 30 et 60 pour cent des anomalies d6eouvertcs fortuitement par les tests pr~op6mtoires ne sont pas not6es duns cette p6riode. Ceci est nettement le cas des rayons-x pulmonaires pr6op6ratoires ou les r6sultats n'6taient pas darts le dossier lots du d6but de l'anesth6sie. Une anomalie non explor~e ad~quatement repr6sente une plus grande responsabilit6 16gale qu'une anomalie non d~tect6e en p~riode pr~ot~ratoire. 511 apparait ainsi qu'un surplus de test, qu'un test non indiqu6 par I'histoire, repr~sente un risque suppl4mentairr aux patients ainsi qu'un plus grand dsque mCdieo-l~gal pour le m6decin.
Ainsi le seul avantage ~ continuer le present syst6me de dOpistage de routine serait de b~itir une c6dule op6ratoire effieace par des ehirurgiens tentam d'appaiser les anesth6siologistes. Ce qui pourra r6soudre le probl~me est un systOme (avec l'accord du ehirurgien et de l'ancsth6-siologiste et bus6 sur le jugement clinique) o~ Fanesth6siologiste admet que eertaines conditions demandent des tests sp6cifiques et d'autres conditions n'en requiOrent point. Si quelqu'un pouvait automatiser ce syst~me les chirurgiens ponrraient l'instaurer de la mOme fa~on qu'ils demandent actuellement les batteries de tests. Ce qui apparaSt n6eessaire afin de diminuer le taux d'erreurs darts la demande des tests serait un syst~me bas~ sur uric histoire mCdicale ~ partir de laquelle on sugg~re des tests. On a essay6 un protocole o~ le r6sultat de l'histoire rempli par le patient sur six pages de questionnaire sugg~re lequel des tests de laboratoire doivent ~tre demand(~s. 3'6 Ce syst~n~e fonctionnait uniquement quand une infirmih'e de recherche ~tait pr6sente afin d'int6grer les r6sultats de l'histoire darts les indications pr6alable-merit sngg6r6es pour chaque test. 11 est 6vident qu'un syst~me automatis6 serait n6cessaire car I'embauche d'une infirmi~re serait plus co0teux que le test lui-m~me. On a essay6 un syst~me prograram6 sur Macintosh sans succ~s ear plusieurs patients n'6taient pas familiers avec les ordinateurs. Actuellement on essaie un autre syst~me qui fournit au patient un "quiz de sant6" sur un simple ordinateur tt quatre boutons identiques au jeu de "Donkey Kong, Jr". Le chirurgien on l'anesth6siste aurait cet appareil dans leur bureau. L'appareil demande an patient des questions dont les r~ponses sont des simples "oui" ou "non" et imprime leurs r4ponses ainsi que les tests de laboratoires sugg6r6s se basant sur les indications pr6-6tablies. Le m&lecin, le chirurgien, ou anesth6siologiste peut cependant passer outre ou ajouter anx tests sugg4r~s par ce syst~me avant que les tests pr6o1~ratoires soient demandCs.
Ainsi qu'un m6canisme d'application facile soit disponible ou pas il apparatt qu'on a besoin de diminuer le hombre de test. Moins de test rd~cluit le risque au patient, r6duit les risqucs m~dieo-16gaux pour le m6decin, r6duit les coots b. la soci~t,: et rend probablement la e6dule op6ratoire plus efficaee. Je pense que le temps est arrive pour que les travaux comme ceux de Charpak et aL am~nent dans le futur un b6n6fice ~. la soci6t6 en diminuant le nombre des tests pr6op6ratoires et en les rendam plus appropri6s.
